Mode
Text Size
Log in / Sign up
N/A Completed N=31,303 Randomized Screening

The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale

Lung Cancer · Lung Neoplasms/Diagnosis
Source: ClinicalTrials.gov NCT06338592 ↗
Enrolled (actual)
31,303
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcomePrimary: Study 1 Primary Outcome: Count of Patients Newly Identified as Eligible for Lung Cancer Screening — 308; 635 Participants

Summary

Early lung cancer screening (LCS) through low-dose computed tomography (LDCT) is crucial but underused due to various barriers, including incomplete or inaccurate patient smoking data in the electronic health record and limited time for shared decision-making. The objective of this trial is to investigate a patient-centered intervention, MyLungHealth, delivered through the patient portal. The intervention is designed to improve LCS rates through increased identification of eligible patients and informed decision making.

Outcome Measures

OutcomeResultp-value
PRIMARY
Study 1 Primary Outcome: Count of Patients Newly Identified as Eligible for Lung Cancer Screening
308; 635
PRIMARY
Study 2 Primary Outcome: Count of Participants for Whom LDCT Was Ordered.
434; 474
SECONDARY
Study 1 Secondary Outcome: Count of Participants for Whom LDCT Eligibility Status Became Known.
925; 3,570
SECONDARY
Study 1 Secondary Outcome: Count of Participants for Whom LDCT Was Ordered.
350; 430
SECONDARY
Study 1 Secondary Outcome: Count of Participants for Whom LDCT Was Completed.
226; 275
SECONDARY
Study 2 Secondary Outcome: Count of Participants for Whom LDCT Was Completed.
290; 293

Eligibility Criteria

Inclusion criteria for both study 1 and study 2:

  • aged 50-79
  • a history of smoking (e.g., current or former tobacco use)
  • seen in a study primary care clinic in the 12 months preceding the start of the trial

Exclusion criteria for both study 1 and study 2:

  • >0 but < 10 pack-year smoking history or quit more than 15 years ago
  • No use of the patient portal at least once in the year preceding the start of the study
  • A lung cancer diagnosis at the start of the study
  • LDCT completed in the past 3 years
  • Another chest CT completed in the past year
  • Structured EHR data indicating LCS SDM was provided in the past 3 years
  • Exposed to the intervention during the pilot phase
  • No visit at a study clinic during the trial period when the intervention was available

Inclusion criteria for study 1:

  • a 10-19 pack-year smoking history, an unknown pack-year history, unknown quit date for patients who quit smoking, or a 0 pack-year smoking history

Inclusion criteria for study 2:

  • at least a 20 pack-year smoking history and are a current smoker or have quit within the last 15 years
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06338592). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search